Hong-wei Sun

Guangdong Provincial Key Laboratory Of Tumor Interventional Diagnosis And Treatment
Zhuhai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Triptolide impacts CSF1R expression and reprograms the suppressive function of myeloid-derived suppressor cells via targeting the ER stress pathway.

Triptolide impacts CSF1R expression and reprograms the suppressive function of myeloid-derived suppressor cells via targeting the ER stress pathway.

Journal: Cytokine

Published: August 11, 2025

KIRA6 restrains the generation of myeloid-derived suppressor cells and overcomes resistance to anti-PD-1 therapy.

KIRA6 restrains the generation of myeloid-derived suppressor cells and overcomes resistance to anti-PD-1 therapy.

Journal: Cell death & disease

Published: July 31, 2025

Glutamate promotes CCL2 expression to recruit tumor-associated macrophages by restraining EZH2-mediated histone methylation in hepatocellular carcinoma.

Glutamate promotes CCL2 expression to recruit tumor-associated macrophages by restraining EZH2-mediated histone methylation in hepatocellular carcinoma.

Journal: Oncoimmunology

Published: April 24, 2025

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma.

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: September 09, 2024

RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity.

RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity.

Journal: EMBO molecular medicine

Published: November 22, 2023

ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.

ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.

Journal: Cell chemical biology

Published: March 22, 2022

Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF.

Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF.

Journal: Frontiers in immunology

Published: October 12, 2020

Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer.

Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer.

Journal: Cancer immunology research

Published: May 08, 2020

Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer.

Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer.

Journal: Signal transduction and targeted therapy

Published: April 20, 2020

Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients.

Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients.

Journal: Oncoimmunology

Published: May 13, 2019

Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer.

Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer.

Journal: Cancer immunology research

Published: December 15, 2018

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.

Journal: PloS one

Published: October 18, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026